|
US5082767A
(en)
|
1989-02-27 |
1992-01-21 |
Hatfield G Wesley |
Codon pair utilization
|
|
US6140496A
(en)
|
1990-10-09 |
2000-10-31 |
Benner; Steven Albert |
Precursors for deoxyribonucleotides containing non-standard nucleosides
|
|
US5891680A
(en)
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
|
US5811097A
(en)
|
1995-07-25 |
1998-09-22 |
The Regents Of The University Of California |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
|
|
US5922685A
(en)
|
1996-06-05 |
1999-07-13 |
Powderject Vaccines, Inc. |
IL-12 gene therapy of tumors
|
|
EP0931156A2
(en)
|
1996-10-18 |
1999-07-28 |
Valentis Inc. |
Gene expression and delivery systems and uses
|
|
US5994104A
(en)
|
1996-11-08 |
1999-11-30 |
Royal Free Hospital School Of Medicine |
Interleukin-12 fusion protein
|
|
AU744755B2
(en)
|
1997-11-12 |
2002-03-07 |
Brigham And Women's Hospital |
The translation enhancer element of the human amyloid precursor protein gene
|
|
JP2001523480A
(ja)
|
1997-11-20 |
2001-11-27 |
バイカル インコーポレイテッド |
サイトカイン発現ポリヌクレオチドおよびそれらの組成物を用いた癌の処置
|
|
WO1999054455A1
(fr)
|
1998-04-23 |
1999-10-28 |
Takara Shuzo Co., Ltd. |
Procede de synthese de l'adn
|
|
AU761520B2
(en)
|
1998-09-15 |
2003-06-05 |
Genetics Institute, Llc |
Treatment of Kaposi's Sarcoma with IL-12
|
|
AU6270499A
(en)
|
1998-09-29 |
2000-04-17 |
Phylos, Inc. |
Synthesis of codon randomized nucleic acids
|
|
NZ517202A
(en)
|
1999-08-24 |
2004-05-28 |
Medarex Inc |
Human CTLA-4 antibodies and their uses
|
|
EP1248654B1
(en)
|
2000-01-20 |
2005-10-05 |
Universität Zürich Institut für Medizinische Virologie |
Intra-tumoral administration of il-12 encoding naked nucleic acid molecules
|
|
US7468275B2
(en)
|
2000-01-28 |
2008-12-23 |
The Scripps Research Institute |
Synthetic internal ribosome entry sites and methods of identifying same
|
|
WO2001055371A1
(en)
|
2000-01-28 |
2001-08-02 |
The Scripps Research Institute |
Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
|
|
ES2164011B1
(es)
|
2000-02-25 |
2003-05-16 |
Inst Cientifico Tecnol Navarra |
Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos.
|
|
ES2272448T3
(es)
|
2000-03-15 |
2007-05-01 |
Genexine Co., Ltd. |
Genes de la subunidad il-12p40 mutados para mejorar la actividad de il-12 y uso de los mismos en un coadyuvante de vacuna genetica.
|
|
KR20020010206A
(ko)
|
2000-07-27 |
2002-02-04 |
이시우 |
인터루킨 12와 보조활성인자 ｂ7.1 유전자를 함유하는ｄｎａ 벡터 및 이벡터가 도입된 항암 세포백신
|
|
ATE291925T1
(de)
|
2001-06-05 |
2005-04-15 |
Curevac Gmbh |
Stabilisierte mrna mit erhöhtem g/c-gehalt und optimierter codon usage für die gentherapie
|
|
US6875611B2
(en)
|
2001-07-03 |
2005-04-05 |
University Of Utah Research Foundation |
Soluble steroidal peptides for nucleic acid delivery
|
|
EP2428570B1
(en)
|
2001-09-28 |
2018-05-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microrna molecules
|
|
EP1452593B1
(en)
|
2001-11-14 |
2009-04-08 |
Toyo Boseki Kabushiki Kaisha |
Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
|
|
CA2409775C
(en)
|
2001-12-03 |
2010-07-13 |
F. Hoffmann-La Roche Ag |
Reversibly modified thermostable enzymes for dna synthesis and amplification in vitro
|
|
EP1490494A1
(en)
|
2002-04-01 |
2004-12-29 |
Walter Reed Army Institute of Research |
Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
|
|
US7595303B1
(en)
|
2002-09-05 |
2009-09-29 |
University Of South Florida |
Genetic adjuvants for immunotherapy
|
|
DE10248141B4
(de)
|
2002-10-11 |
2007-04-19 |
Universitätsklinikum Hamburg-Eppendorf |
Nukleinsäuren und deren Verwendung für die Gentherapie
|
|
DE10260805A1
(de)
|
2002-12-23 |
2004-07-22 |
Geneart Gmbh |
Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins
|
|
CN1798502A
(zh)
|
2003-05-30 |
2006-07-05 |
南佛罗里达大学 |
治疗恶性肿瘤的方法
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
GB0329146D0
(en)
|
2003-12-16 |
2004-01-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
EP1640018A1
(en)
|
2004-09-24 |
2006-03-29 |
Universität Zürich |
Combinational therapy for treating cancer
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
US7550264B2
(en)
|
2005-06-10 |
2009-06-23 |
Datascope Investment Corporation |
Methods and kits for sense RNA synthesis
|
|
AU2006265896B2
(en)
|
2005-06-30 |
2012-05-31 |
Archemix Corp. |
Materials and methods for the generation of fully 2'-modified nucleic acid transcripts
|
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
PL2578685T3
(pl)
|
2005-08-23 |
2020-01-31 |
The Trustees Of The University Of Pennsylvania |
Rna zawierający zmodyfikowane nukleozydy i sposoby jego zastosowania
|
|
JP5225087B2
(ja)
|
2005-08-24 |
2013-07-03 |
ザ スクリプス リサーチ インスティチュート |
翻訳エンハンサーエレメント依存性のベクター系
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
SI1966238T1
(sl)
|
2005-12-30 |
2012-08-31 |
Merck Patent Gmbh |
Variante interlevkina-12P40 z izboljšano stabilnostjo
|
|
WO2007081680A2
(en)
|
2006-01-05 |
2007-07-19 |
The Ohio State University Research Foundation |
Microrna expression abnormalities in pancreatic endocrine and acinar tumors
|
|
EP2484782B1
(en)
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
US7833754B2
(en)
|
2006-01-13 |
2010-11-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
IL-12 for expression in mammalian cell
|
|
KR101241477B1
(ko)
|
2006-01-27 |
2013-03-08 |
엘지이노텍 주식회사 |
질화물 반도체 발광소자 및 그 제조 방법
|
|
EP2522748A1
(en)
|
2006-03-02 |
2012-11-14 |
The Ohio State University |
MicroRNA expression profile associated with pancreatic cancer
|
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
|
WO2007113648A2
(en)
|
2006-04-05 |
2007-10-11 |
Pfizer Products Inc. |
Ctla4 antibody combination therapy
|
|
US20080046192A1
(en)
|
2006-08-16 |
2008-02-21 |
Richard Lathrop |
Polypepetide-encoding nucleotide sequences with refined translational kinetics and methods of making same
|
|
CA2664383C
(en)
|
2006-09-19 |
2017-08-22 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
WO2008054828A2
(en)
|
2006-11-01 |
2008-05-08 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
CN101622348A
(zh)
|
2006-12-08 |
2010-01-06 |
奥斯瑞根公司 |
作为治疗性干预靶标的miR-20调节的基因和途径
|
|
AU2007337810B2
(en)
|
2006-12-22 |
2014-02-13 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
US8765462B2
(en)
|
2007-05-04 |
2014-07-01 |
University Health Network |
IL-12 immunotherapy for cancer
|
|
US8415096B2
(en)
|
2007-05-23 |
2013-04-09 |
University Of South Florida |
Micro-RNAs modulating immunity and inflammation
|
|
WO2008154098A2
(en)
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
PT2170959E
(pt)
|
2007-06-18 |
2014-01-07 |
Merck Sharp & Dohme |
Anticorpos para o receptor humano de morte programada pd-1
|
|
US20090028857A1
(en)
|
2007-07-23 |
2009-01-29 |
Cell Genesys, Inc. |
Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
|
|
TWI359030B
(en)
|
2007-08-24 |
2012-03-01 |
Univ Nat Taiwan |
Treatment of cellular proliferative disorders
|
|
PT2201100E
(pt)
|
2007-09-14 |
2016-06-03 |
Univ Brussel Vrije |
Aperfeiçoamento da capacidade estimulatória de células t das células que apresentam antígeno humano e o seu uso na vacinação
|
|
WO2009039198A2
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of The University Of Pennsylvania |
Generation of hyperstable mrnas
|
|
JP5624471B2
(ja)
*
|
2007-09-24 |
2014-11-12 |
バーイラン ユニバーシティー |
磁性金属酸化物で被覆されたポリマー性ナノ粒子及びその使用
|
|
DK2205618T3
(en)
|
2007-09-26 |
2017-02-20 |
Intrexon Corp |
SYNTHETIC 5 'NON-TRANSLATED REGIONS, EXPRESSION VECTORS AND PROCEDURES FOR INCREASING TRANSGENIC EXPRESSION
|
|
EP2225396A4
(en)
|
2007-11-30 |
2011-03-02 |
Univ Ohio State Res Found |
PROFILING AND SCREENING OF MICRO-RNA EXPRESSION IN PERIPHERAL BLOOD IN LUNG CANCER
|
|
SG10201408164XA
(en)
|
2007-12-11 |
2015-01-29 |
Scripps Research Inst |
Compositions and methods related to mrna translational enhancer elements
|
|
EP2072618A1
(en)
|
2007-12-14 |
2009-06-24 |
Johannes Gutenberg-Universität Mainz |
Use of RNA for reprogramming somatic cells
|
|
EP3100718B1
(en)
*
|
2008-01-02 |
2019-11-27 |
Arbutus Biopharma Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
WO2009100430A2
(en)
|
2008-02-08 |
2009-08-13 |
Asuragen, Inc |
miRNAs DIFFERENTIALLY EXPRESSED IN LYMPH NODES FROM CANCER PATIENTS
|
|
JP2011517932A
(ja)
|
2008-02-28 |
2011-06-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト慢性リンパ球性白血病（ｃｃｌ）と関連するマイクロｒｎａシグネチャーおよびその使用
|
|
EP2279254B1
(en)
*
|
2008-04-15 |
2017-07-05 |
Protiva Biotherapeutics Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
EP2112235A1
(en)
|
2008-04-24 |
2009-10-28 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
|
|
US8715964B2
(en)
|
2008-05-11 |
2014-05-06 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Expression of IL-12 family heterodimers
|
|
US8401798B2
(en)
|
2008-06-06 |
2013-03-19 |
Dna Twopointo, Inc. |
Systems and methods for constructing frequency lookup tables for expression systems
|
|
US7561973B1
(en)
|
2008-07-31 |
2009-07-14 |
Dna Twopointo, Inc. |
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
|
US8126653B2
(en)
|
2008-07-31 |
2012-02-28 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
|
WO2009149539A1
(en)
|
2008-06-10 |
2009-12-17 |
Université de Montréal |
Enhancing antigen-specific cd8+ t cell response using irf-7 mrna
|
|
WO2010018563A2
(en)
|
2008-08-12 |
2010-02-18 |
Rosetta Genomics Ltd. |
Compositions and methods for the prognosis of lymphoma
|
|
EA201500417A1
(ru)
|
2008-08-25 |
2015-11-30 |
Эмплиммьюн, Инк. |
Композиции антагонистов pd-1 и способы применения
|
|
US9074206B2
(en)
|
2008-11-13 |
2015-07-07 |
Fudan University |
Compositions and methods for micro-RNA expression profiling of colorectal cancer
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
US20120053224A1
(en)
|
2008-12-10 |
2012-03-01 |
Universitat Regensburg |
Compositions and methods for micro-rna expression profiling of cancer stem cells
|
|
WO2010126766A1
(en)
*
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
US20120264626A1
(en)
|
2009-05-08 |
2012-10-18 |
The Ohio State University Research Foundation |
MicroRNA Expression Profiling and Targeting in Chronic Obstructive Pulmonary Disease (COPD) Lung Tissue and Methods of Use Thereof
|
|
KR20220038506A
(ko)
|
2009-06-10 |
2022-03-28 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
EA022786B1
(ru)
|
2009-07-31 |
2016-03-31 |
Этрис Гмбх |
Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
|
|
EP2281579A1
(en)
|
2009-08-05 |
2011-02-09 |
BioNTech AG |
Vaccine composition comprising 5'-Cap modified RNA
|
|
US20110082055A1
(en)
|
2009-09-18 |
2011-04-07 |
Codexis, Inc. |
Reduced codon mutagenesis
|
|
EP2504028A4
(en)
|
2009-11-24 |
2014-04-09 |
Amplimmune Inc |
SIMULTANEOUS INHIBITION OF PD-L1 / PD-L2
|
|
SI2506857T1
(en)
|
2009-12-01 |
2018-08-31 |
Translate Bio, Inc. |
Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases
|
|
WO2011076143A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expression profiling of lung cancer
|
|
WO2011076142A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expession profiling in plasma of colorectal cancer
|
|
EP2341145A1
(en)
|
2009-12-30 |
2011-07-06 |
febit holding GmbH |
miRNA fingerprint in the diagnosis of diseases
|
|
WO2011094683A2
(en)
|
2010-01-29 |
2011-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Method of identifying myelodysplastic syndromes
|
|
EP2354246A1
(en)
|
2010-02-05 |
2011-08-10 |
febit holding GmbH |
miRNA in the diagnosis of ovarian cancer
|
|
US20130059015A1
(en)
|
2010-03-11 |
2013-03-07 |
H. Lee Moffitt Cancer Center & Research Institute |
Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
|
|
WO2011157294A1
(en)
|
2010-06-16 |
2011-12-22 |
Universita' Degli Studi Di Padova |
Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
|
|
US20130230884A1
(en)
|
2010-07-16 |
2013-09-05 |
John Chaput |
Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation
|
|
WO2012038448A1
(en)
|
2010-09-21 |
2012-03-29 |
Riboxx Gmbh |
Method for synthesizing rna using dna template
|
|
WO2012072096A1
(en)
|
2010-12-03 |
2012-06-07 |
Biontech Ag |
Method for cellular rna expression
|
|
KR20120066952A
(ko)
|
2010-12-15 |
2012-06-25 |
주식회사 롤팩 |
7층 구조의 공압출 항균 진공포장 필름 및 그 제조방법
|
|
CA2821622C
(en)
|
2010-12-16 |
2019-09-03 |
Sprna Gmbh |
Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
|
|
WO2012116714A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in elderly patients
|
|
ES2699965T3
(es)
|
2011-03-10 |
2019-02-13 |
Provectus Pharmatech Inc |
Una combinación de rosa de bengala y anticuerpo anti-CTLA4 para su uso en el tratamiento del cáncer
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
WO2012151212A1
(en)
|
2011-05-01 |
2012-11-08 |
University Of Rochester |
Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
|
|
US9281930B2
(en)
|
2011-05-02 |
2016-03-08 |
Lg Electronics Inc. |
Method for transmitting/receiving data in wireless access system and base station for same
|
|
US20130042333A1
(en)
|
2011-05-06 |
2013-02-14 |
Jean-Gabriel JUDDE |
Markers for cancer prognosis and therapy and methods of use
|
|
KR20220025112A
(ko)
|
2011-06-08 |
2022-03-03 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Mrna 전달을 위한 지질 나노입자 조성물 및 방법
|
|
JP5965481B2
(ja)
|
2011-07-15 |
2016-08-03 |
レオ ファーマ アクティーゼルスカブ |
皮膚ｔ細胞リンパ腫（ｃｔｃｌ）の診断用マイクロｒｎａプロファイリング
|
|
WO2013033640A1
(en)
|
2011-09-01 |
2013-03-07 |
Allegro Diagnostics Corp. |
Methods and compositions for detecting cancer based on mirna expression profiles
|
|
WO2013039857A1
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
PL3351261T3
(pl)
|
2011-10-11 |
2021-12-06 |
Universität Zürich |
Lek złożony zawierający IL-12 i środek do blokowania cząsteczek hamujących komórki T w terapii nowotworów
|
|
US20140243240A1
(en)
|
2011-10-26 |
2014-08-28 |
Georgetown University |
microRNA EXPRESSION PROFILING OF THYROID CANCER
|
|
BR112014012819B1
(pt)
|
2011-11-28 |
2022-08-16 |
Merck Patent Gmbh |
Anticorpo anti-pd-l1 ou fragmento de ligação ao antígeno do mesmo e composição
|
|
CN104245719B
(zh)
|
2011-12-12 |
2016-09-14 |
宾夕法尼亚大学托管会 |
包含改进的il-12基因构建体的组合物和疫苗、免疫治疗剂及其使用方法
|
|
EP2623121A1
(en)
|
2012-01-31 |
2013-08-07 |
Bayer Innovation GmbH |
Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
US9856320B2
(en)
|
2012-05-15 |
2018-01-02 |
Bristol-Myers Squibb Company |
Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
|
|
EP2672197A1
(de)
|
2012-06-06 |
2013-12-11 |
Hörmann Energietechnik GmbH & Co. KG |
Montageanordnung zur dachseitigen Montage von Flächenkörpern an einem Bauwerk
|
|
EP3536787A1
(en)
|
2012-06-08 |
2019-09-11 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
|
EA201492055A1
(ru)
|
2012-06-08 |
2015-11-30 |
Шир Хьюман Дженетик Терапис, Инк. |
ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ
|
|
US20140020675A1
(en)
|
2012-07-18 |
2014-01-23 |
Chandrashekhar Sonwane |
Solar receiver
|
|
US9512456B2
(en)
|
2012-08-14 |
2016-12-06 |
Modernatx, Inc. |
Enzymes and polymerases for the synthesis of RNA
|
|
CN103555734B
(zh)
*
|
2012-09-17 |
2015-07-15 |
青岛康立泰药业有限公司 |
人白细胞介素-12的编码基因、真核宿主细胞和表达方法
|
|
WO2014093924A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
WO2014071963A1
(en)
|
2012-11-09 |
2014-05-15 |
Biontech Ag |
Method for cellular rna expression
|
|
PT2922554T
(pt)
*
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
US20150366997A1
(en)
|
2012-12-07 |
2015-12-24 |
Shire Human Genetics Therapies, Inc. |
COMPOSITIONS AND METHODS FOR mRNA DELIVERY
|
|
EP3434774A1
(en)
|
2013-01-17 |
2019-01-30 |
ModernaTX, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
SG11201506052PA
(en)
|
2013-02-22 |
2015-09-29 |
Curevac Gmbh |
Combination of vaccination and inhibition of the pd-1 pathway
|
|
ES2887254T3
(es)
|
2013-03-08 |
2021-12-22 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
WO2014164253A1
(en)
|
2013-03-09 |
2014-10-09 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
|
KR102311614B1
(ko)
|
2013-03-14 |
2021-10-08 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Cftr mrna 조성물 및 관련 방법 및 사용
|
|
EA201591229A1
(ru)
|
2013-03-14 |
2016-01-29 |
Шир Хьюман Дженетик Терапис, Инк. |
Способы очистки матричной рнк
|
|
WO2014152940A1
(en)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
EA201591283A1
(ru)
|
2013-03-14 |
2016-02-29 |
Шир Хьюман Дженетик Терапис, Инк. |
Количественная оценка эффективности кэп матричной рнк
|
|
US10266559B2
(en)
|
2013-03-14 |
2019-04-23 |
Translate Bio, Inc. |
Ribonucleic acids with 4′-thio-modified nucleotides and related methods
|
|
EP3932947A1
(en)
|
2013-03-14 |
2022-01-05 |
Translate Bio MA, Inc. |
Methods and compositions for delivering mrna coded antibodies
|
|
MX2015011945A
(es)
|
2013-03-14 |
2015-12-01 |
Shire Human Genetic Therapies |
Evaluacion cuantitativa para la eficacia de los casquetes de arn mensajero.
|
|
ES2967701T3
(es)
|
2013-03-15 |
2024-05-03 |
Translate Bio Inc |
Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas
|
|
SG10201801428RA
(en)
|
2013-08-21 |
2018-03-28 |
Curevac Ag |
Method for increasing expression of rna-encoded proteins
|
|
SMT202300039T1
(it)
|
2013-09-13 |
2023-03-17 |
Beigene Switzerland Gmbh |
Anticorpi anti-pd1 e loro uso come terapia e per diagnostica
|
|
EP3053592B1
(en)
|
2013-10-01 |
2025-04-23 |
Mie University |
T cell-inducing vaccine containing interepitope sequence promoting antigen presentation
|
|
US20160243221A1
(en)
|
2013-10-18 |
2016-08-25 |
Moderna Therapeutics, Inc. |
Compositions and methods for tolerizing cellular systems
|
|
ES3032935T3
(en)
|
2013-10-22 |
2025-07-29 |
Translate Bio Inc |
Lipid formulations for delivery of messenger rna
|
|
EP3574923A1
(en)
|
2013-10-22 |
2019-12-04 |
Translate Bio, Inc. |
Mrna therapy for phenylketonuria
|
|
WO2015062738A1
(en)
|
2013-11-01 |
2015-05-07 |
Curevac Gmbh |
Modified rna with decreased immunostimulatory properties
|
|
MX2016007965A
(es)
*
|
2013-12-17 |
2016-10-28 |
Genentech Inc |
Terapia de combinacion que comprende agonistas de union a ox40 y antagonistas de union al eje pd-1.
|
|
SG11201604781RA
(en)
*
|
2013-12-18 |
2016-07-28 |
Intrexon Corp |
Single chain il-12 nucleic acids, polypeptids, and uses thereof
|
|
AU2014375402B2
(en)
|
2013-12-30 |
2020-10-01 |
CureVac SE |
Artificial nucleic acid molecules
|
|
CA2927254C
(en)
|
2013-12-30 |
2023-10-24 |
Curevac Ag |
Artificial nucleic acid molecules
|
|
HRP20220070T1
(hr)
*
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
CA2953341C
(en)
*
|
2014-06-25 |
2023-01-24 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
SG11201702295UA
(en)
|
2014-09-22 |
2017-04-27 |
Intrexon Corp |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
WO2016123573A1
(en)
|
2015-01-30 |
2016-08-04 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
AU2016251687C1
(en)
|
2015-04-22 |
2023-07-27 |
CureVac SE |
RNA containing composition for treatment of tumor diseases
|
|
US9636388B2
(en)
|
2015-05-19 |
2017-05-02 |
Morphogenesis, Inc. |
Multi-indication mRNA cancer immunotherapy
|
|
US10682401B2
(en)
|
2015-05-19 |
2020-06-16 |
Morphogenesis, Inc. |
Multi-indication mRNA cancer immunotherapy
|
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
|
EP3205356A1
(en)
|
2016-02-10 |
2017-08-16 |
Onkoloski Institut Ljubljana |
Plasmid expression vector encoding human interleukin 12 under transcriptional control of p21 promoter and without antibiotic resistance for cancer gene therapy and other uses thereof
|
|
EP3211000B1
(en)
|
2016-02-25 |
2019-01-30 |
Provecs Medical GmbH |
Novel immunostimulating vector system
|
|
PL3458083T3
(pl)
|
2016-05-18 |
2023-03-13 |
Modernatx, Inc. |
Polinukleotydy kodujące interleukinę-12 (il12) i ich zastosowania
|
|
CN109715205A
(zh)
|
2016-08-19 |
2019-05-03 |
库瑞瓦格股份公司 |
用于癌症治疗的rna
|
|
CN110267978A
(zh)
|
2016-10-07 |
2019-09-20 |
得克萨斯大学体系董事会 |
用于治疗癌症的表达膜锚定的il-12的t细胞
|